Summary
This cross-sectional study compared gut microbiome profiles across ME/CFS patients, long COVID-19 patients, and healthy controls using 16S rRNA sequencing. Both disease groups showed overlapping but distinct microbiome alterations relative to controls—notably enrichment of Sutterella and depletion of Terrisporobacter and Lachnospiraceae—alongside shared shifts in predicted metabolic pathways related to anaerobic carbon and polyol metabolism. Microbiome variation correlated most strongly with fatigue and physiosomatic symptoms, suggesting potential links between dysbiosis and cardinal symptom domains in both conditions.
Regional applicability
The study geography is not stated in the metadata provided. Transferability to United Kingdom populations would depend on whether the cohorts were geographically representative and whether gut microbiota patterns are consistent across similar healthcare settings; further details on recruitment site(s) would be needed to assess applicability to UK clinical practice.
Key measures
Alpha-diversity indices, beta-diversity (Bray-Curtis dissimilarity), differential abundance of bacterial taxa (Sutterella, Terrisporobacter, Lachnospiraceae), predicted functional pathways (anaerobic carbon metabolism, inositol degradation, phosphonate metabolism, lysine fermentation), symptom-domain scores (fatigue, physiosomatic, affective, cognitive, gastrointestinal)
Outcomes reported
The study compared fecal gut microbiome composition in patients with ME/CFS, long COVID-19, and healthy controls using 16S rRNA profiling, identifying disease-associated bacterial taxa and predicted metabolic pathway alterations.
Topic tags
Dig deeper with Pulse AI.
Ask about this record, its theme or its relevance to UK farming and policy. Pulse AI uses selected catalogue evidence and cites the sources it draws on.